Skip to Primary Navigation

Skip to main content

Biomed investment analyst charged with insider trading

A photo showing mens shoes and a leather briefcase in dark shadows across the floor.
Photo: Jeff Hutchens/Edit by Getty Images

Kevin Kinsella

1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

In parallel enforcement actions, the DOJ and SEC have charged an analyst with two counts each of securities fraud for trading on nonpublic information.

An analyst made hundreds of thousands of dollars in illegal profits by trading in securities based on inside information.

According to the US Attorney for the Southern District of New York, Jianqing Li allegedly used nonpublic information regarding upcoming announcements that he expected would increase or decrease a company’s stock

, , , , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience